PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Cy7 anti-human Siglec-8, 25 tests
PE/Cy7 anti-human SSEA-4, 100 tests
PE/Cy7 anti-human SSEA-4, 25 tests
PE/Cy7 anti-human TCR Va7.2, clone 3C10, 100 tests - BIO351712
PE/Cy7 anti-human TCR Vα24-Jα18 (iNKT cell), 100 tests
PE/Cy7 anti-human TCR Vα24-Jα18 (iNKT cell), 25 tests
PE/Cy7 anti-human TCR Vα7.2, 25 tests
PE/Cy7 anti-human TCR α/β, 100 tests
PE/Cy7 anti-human TCR α/β, 25 tests
PE/Cy7 anti-human TCR γ/δ, 100 tests
PE/Cy7 anti-human TCR γ/δ, 25 tests
PE/Cy7 anti-human TIGIT (VSTM3), 100 tests
PE/Cy7 anti-human TIGIT (VSTM3), 25 tests
PE/Cy7 anti-human Tim-4, 100 tests
PE/Cy7 anti-human Tim-4, 25 tests
PE/Cy7 anti-human TSLPR (TSLP-R), 100 tests